Embla Medical hf.
OSSFF
$4.15
-$0.15-3.49%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.63% | 6.72% | 6.57% | 6.65% | 8.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.63% | 6.72% | 6.57% | 6.65% | 8.81% |
| Cost of Revenue | 9.35% | 4.70% | 3.95% | 1.75% | 6.69% |
| Gross Profit | 8.20% | 7.96% | 8.18% | 9.73% | 10.12% |
| SG&A Expenses | 7.06% | 4.59% | 3.96% | 3.62% | 5.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.34% | 5.06% | 4.24% | 3.08% | 6.29% |
| Operating Income | 10.59% | 18.32% | 24.00% | 35.78% | 28.92% |
| Income Before Tax | 19.19% | 13.75% | 20.87% | 29.17% | 19.15% |
| Income Tax Expenses | 12.44% | 20.32% | 22.54% | 35.27% | 25.56% |
| Earnings from Continuing Operations | 21.30% | 11.81% | 20.37% | 27.38% | 17.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 54.55% | -39.79% | -276.58% | -289.31% | -65.53% |
| Net Income | 22.06% | 11.69% | 19.71% | 26.78% | 16.94% |
| EBIT | 10.59% | 18.32% | 24.00% | 35.78% | 28.92% |
| EBITDA | 11.72% | 14.58% | 19.43% | 29.58% | 26.44% |
| EPS Basic | 21.74% | 12.35% | 20.14% | 25.93% | 15.00% |
| Normalized Basic EPS | 19.71% | 14.35% | 20.60% | 27.64% | 16.83% |
| EPS Diluted | 21.74% | 12.35% | 20.14% | 25.93% | 15.00% |
| Normalized Diluted EPS | 19.71% | 14.35% | 20.60% | 27.64% | 16.83% |
| Average Basic Shares Outstanding | 0.15% | -0.74% | -0.43% | 0.47% | 2.30% |
| Average Diluted Shares Outstanding | 0.15% | -0.74% | -0.43% | 0.47% | 2.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |